跳至主要内容
临床试验/NCT03998956
NCT03998956Unknown不适用

Study of High-density Mapping-guided bOx Isolation and subsTrate Ablation for Persistent Atrial Fibrillation

The Third Xiangya Hospital of Central South University0 个研究点目标入组 200 人开始时间: 2019年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
200
主要终点
sinus rhythm maintenance rate

研究概览

简要总结

This study evaluates the efficacy of high-density mapping guided atrial substrate ablation for persistent atrial fibrillation. 1/5 of the patients with persistent atrial fibrillation undergo pulmonary veins isolation, 2/5 of them pulmonary veins and box isolation while others undergo atrial substrate ablation apart from pulmonary veins and box isolation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent signed.
  • Age of 18 to 75 years old.
  • Persistent or longstanding persistent atrial fibrillation (≥7 days), which is confirmed by Holter in recent six months.
  • Willing to have catheter ablation for atrial fibrillation.

排除标准

  • Accompanied by serious heart diseases including cardiac valvular diseases, congenital heart diseases, hypertrophic obstructive cardiomyopathy, acute myocardium infarction, unstable anginal pectoris and so on.
  • Complete atrioventricular block.
  • An acute stroke or contradiction of anti-coagulation.
  • Hyperthyroidism.
  • Having a history of catheter ablation of atrial fibrillation.
  • Left atrial appendage thrombosis confirmed by transesophageal echocardiography.
  • Pregnancy or lactation.
  • Planning for pregnancy in the near future.
  • Myopathy or active liver disease, including patients with sustained increase of serum transaminase of unknown reason and the ones with increased serum transaminase over three times the upper limit of normal.
  • Patients of severe renal insufficiency with creatinine clearance lower than 30 ml/min.

研究组 & 干预措施

Circumferential PV isolation

Active Comparator

Circumferential PV isolation only

干预措施: CPVI (Procedure)

Circumferential PV and BOX isolation

Experimental

Circumferential PV and BOX isolation

干预措施: CPVI+BOX (Procedure)

circumferential PV and BOX isolation with substrate ablation

Experimental

Atrial substrate ablation apart from circumferential PV and BOX isolation

干预措施: CPVI+BOX+SUB (Procedure)

结局指标

主要结局

sinus rhythm maintenance rate

时间窗: 12 months

Holter is performed 12months after the procedure and heart rhythm is recorded.

次要结局

  • left ventricular ejection fraction(12 months)
  • Stroke or embolic events(12 months)
  • Atrial fibrosis(1 day)

研究者

申办方类型
Other
责任方
Sponsor

相似试验